Our team and collaborators recently published a study in Diabetes Care evaluating whether population-wide screening for type 1 diabetes is worth the cost. The study shows that broader screening can detect substantially more children at risk for the disease, though at increased healthcare costs. These findings help inform ongoing discussions about early detection programs and the future of type 1 diabetes prevention.